Chofu, Japan

Shoji Yoshimura

This inventor holds 1 USPTO granted patent. Top assignee: Kohjin Co., Ltd.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shoji Yoshimura. Retrieved from https://idiyas.com/inventor/shoji-yoshimura-m7sl9hqv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shoji Yoshimura

Introduction

Shoji Yoshimura is a notable inventor based in Chofu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic properties. His work has led to advancements in anti-inflammatory and analgesic medications.

Latest Patents

Yoshimura holds a patent for (E)-2-[p-(.beta.-substituted-vinyl)phenyl]alkanoic acids. This compound is represented by the formula (I) and is known for its anti-inflammatory, analgesic, antipyretic, and platelet aggregation inhibitory activities. His innovative approach to drug formulation has the potential to improve patient outcomes in various medical conditions.

Career Highlights

Throughout his career, Yoshimura has been associated with Kohjin Co., Ltd., where he has contributed to research and development efforts. His expertise in medicinal chemistry has been instrumental in the creation of effective pharmaceutical products.

Collaborations

Yoshimura has worked alongside talented colleagues such as Susumu Takahashi and Motonobu Ichino. Their collaborative efforts have fostered an environment of innovation and creativity within their research team.

Conclusion

Shoji Yoshimura's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medicine. His patent for (E)-2-[p-(.beta.-substituted-vinyl)phenyl]alkanoic acids highlights his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…